Results 1 - 2 of 2
This Just In: Upgrades and Downgrades
Rodman & Renshaw on Genentech: The patient will live.
These stocks have recently received higher ratings from investors. Will they be a flash in the pan, or are they ready to shine?
Results 1 - 2 of 2